The present invention discloses a personal care composition comprising: (a) A polyvalent metal salt of pyrithione; (b) A metal complex selected from the group consisting of: ##STR00001## wherein Y.sub.1, Y.sub.2, Z.sub.1, Z.sub.2 are selected from the following groups: —NH.sub.2, —NHR.sub.11, —NR.sub.12R.sub.12, —NHCO—R.sub.20, —SH, —OR.sub.13, —O(C═O)—, phosphate. and wherein at least one of Y.sub.1 and Z.sub.1 of compound I is —SH, and wherein at least one of Y.sub.2 and Z.sub.2 of compound II is —SH R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.9, R.sub.10, can independently be H, alkyl, substituted alkyl, phenyl, aryl; R.sub.14 is —NH.sub.2, —NHCO—CH.sub.3, —NHR.sub.17, or —NR.sub.18R.sub.18 R.sub.15 is —COOH, —COOR.sub.19 R.sub.11, R.sub.12, R.sub.13 R.sub.16, R.sub.17, R.sub.18, R.sub.19 can be independently be alkyl, substituted alkyl, phenyl, aryl. and wherein the metal of the complex is selected from the group consisting of zinc, copper, and iron.

This invention relates to a process for preparing an inverse emulsion comprising mixing an aqueous solution comprising a water-soluble (co)polymer A synthesized from at least one cationic monomer and an inverse EMI 2 emulsion comprising a water-soluble (co)polymer B synthesized from at least one cationic monomer, optionally followed by distillation. This invention also relates to the inverse emulsion thus obtained, a detergent or cosmetic or softening composition comprising such an inverse emulsion, as well as the use of such an inverse emulsion to improve the softening properties of a fabric softening composition.

A cosmetic composition in the form of an oil-in-water emulsion comprises (i) at least one solid fatty alcohol; (ii) at least one amino acid surfactant; and (iii) at least one gelling agent selected from hydrophilic acrylic homopolymers and amphiphilic acrylic polymers. A non-therapeutic method for caring for the skin comprises applying said cosmetic composition to the skin.

A polyurethane elastomeric rubber composition containing a bio-based polyol cross-linked with a bio-based isocyanate using a urethanation catalyst such as a bismuth catalyst in the presence of a cosmetic emollient is disclosed. The cross-linked polyurethane elastomer rubber is in further aspect of the invention included in a gel after being milled in the presence of a bio-based emollient or mixture of bio-based emollients. The polyurethane elastomeric gel has good compatibility with cosmetic and natural oils and can be used as a gelling agent for these oils among other desirable cosmetic formulary roles.

A recombinant human type XVII collagen consists of an amino acid sequence shown in (A).sub.n or includes the amino acid sequence shown in (A).sub.n, where A is a sequence set forth in SEQ ID NO: 2, a sequence undergoing an amino acid modification to a predetermined extent based on SEQ ID NO: 2, or a sequence that has more than 80% homology with SEQ ID NO: 2; n is an integer greater than or equal to 1; and A represents a basic unit, and when there are two or more basic units, the two or more basic units are identical or different and are directly connected in tandem through a peptide bond. In the present disclosure, it is confirmed that the recombinant human type XVII collagen can undergo efficient secretory and soluble expression in eukaryotic host cells such as Pichia pastoris (P. pastoris).

The present invention relates to compounds of formula (I) as defined herein. The compounds are suitable for protection against ultraviolet (UV) radiation. Further, the present invention is concerned with compositions comprising at least one compound of formula (I).

##STR00001##

Compositions and methods are provided for producing crystalline forms of organic acids or salts or lactones thereof from an aqueous solution. More specifically, methods are provided for producing a crystalline form of a salt of mevalonic acid (also referred to as X-MVA) from an aqueous solution, comprising subjecting the aqueous solution comprising said X-MVA to a purification step to produce a purified solution and crystallizing said X-MVA from said purified solution by water solvent crystallization. Methods are also provided for producing mevalonolactone from an aqueous solution comprising X-MVA, comprising subjecting the aqueous solution comprising said X-MVA to cation exchange thereby converting said aqueous solution comprising X-MVA to an aqueous solution comprising mevalonolactone (MVL). Methods are also provided for producing mevalonolactone monohydrate crystals.

The objective of the present invention is to provide a thickener that can increase the viscosity of a composition while suppressing stickiness and maintaining a good feeling when the composition is applied on the skin or the like, since the thickener does not contain a polymer thickener or the amount of the polymer thickener is small. The thickener of the present invention is characterized by comprising a phospholipid and a biosurfactant, wherein a ratio of the phospholipid to 1 part by mass of the biosurfactant is greater than 4:1 and less than or equal to 10:1.

C12-15 Alkyl Benzoates that are made at least in part from natural sources, e.g., from various plant based alkyl compounds having chain lengths in the range of 12 to 15 carbon atoms, e.g., palm-based C12 compounds, that are useful for a full array of cosmetic uses, including in all known uses for known C12-15 Alkyl Benzoates, which C12-15 Alkyl Benzoates provide a large number of advantages over known products in the art, including costs savings as well as providing a more natural product, which would be more desirable especially in the fields of uses of cosmetics, and beauty and/or body care products as well as in fragrances, where naturally sourced materials are typically highly valued by customers.

The present invention relates to: a composition for wound healing, containing a metal-organic framework (MOF)as an active ingredient; and a wound dressing material comprising a hydrophilic superabsorbent polymer and the MOF, and the composition and the wound dressing material have a wound healing ability, specifically, the excellent effect of healing a wound by promoting fibroblast movement, do not significantly differ from a control group with respect to cytotoxicity, thereby exhibiting excellent safety when applied to a wound site, and have the excellent effect of having a wound recovery rate high enough to be checked with the naked eye over time.